The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
TREM2 — a key player in microglial biology and Alzheimer disease
Abstract
Alzheimer disease (AD) is a debilitating dementia believed to result from the deposition of extracellular amyloid-β (Aβ)-containing plaques followed by the formation of neurofibrillary tangles. Familial AD typically results from mutations in the genes encoding amyloid precursor protein (APP), presenilin 1 or presenilin 2. Variations in triggering receptor expressed on myeloid cells 2 (TREM2), one of several genes for which expression is restricted to microglia in the brain, have now been shown to increase the risk of developing late-onset AD. Microglia have been shown to respond to Aβ accumulation and neurodegenerative lesions, progressively acquiring a unique transcriptional and functional signature and evolving into disease-associated microglia (DAM). DAM attenuate the progression of neurodegeneration in certain mouse models, but inappropriate DAM activation accelerates neurodegenerative disease in other models. TREM2 is essential for maintaining microglial metabolic fitness during stress events, enabling microglial progression to a fully mature DAM profile and ultimately sustaining the microglial response to Aβ-plaque-induced pathology. Here, we review the current data detailing the role of TREM2 in microglial biology and AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREM2 engagement with ligands triggers the phosphorylation of the DAP12 ITAM, subsequently initiating a cascade of activation of downstream kinases, such as AKT, MAPK, and mTOR29,30.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [30]
In the citing paper
“These kinases are centrally involved in controlling cell metabolism, survival, proliferation, and phagocytosis29,30.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [30]
In the citing paper
“TREM2 engagement leads to DAP12 phosphorylation, followed by recruitment and activation of the spleen-associated tyrosine kinase (SYK), resulting in downstream signaling events leading to proliferation, survival, phagocytosis, and secretion of cytokines and chemokines [47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“The general consensus is that TREM2 is expressed by microglia in the CNS, especially after activation [6, 21, 47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“TREM2 binds on the membrane to the DNAX-activation protein 12 (DAP12) which is an adaptor protein required for TREM2 surface expression and intracellular signaling [47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“In comparison to previous studies which are aligned to the concept that suppressing microglial function may be beneficial in the setting of AD [49], the data described here, together with studies on TREM2 and other AD-associated variants, suggest that a different directionality may be therapeutically useful [6, 46, 50].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [46]
In the citing paper
“One receptor acting upstream of Plcg2 and evoking such responses in innate immune cells might be Trem2 [17, 46].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [46]
In the citing paper
“TREM2 is one of the key receptors modulating PLCγ2 activity [12, 36, 37].”
From Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers (2026) · cites this paper as [36]
In the citing paper
“Although TREM2 is expressed on the cell surface, it is cleaved from the cell surface by metalloproteases and released as soluble TREM2 (sTREM2) (Ulland and Colonna, 2018).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“TREM2 has been extensively studied in microglia for its capacity to sustain microglial responses to neurodegenerative pathologies such as Alzheimer’s disease (Ulland and Colonna, 2018).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“This could be representative of changes in TREM2 expression or shedding, both of which are altered during ageing and disease [55], thereby reducing TREM2-mediated signalling and subsequent conversion of microglia to DAM [56].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [56]
In the citing paper
“Rac is known to be activated downstream of TREM2/DAP12 via Syk and Vav2/3 activation [56].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [56]
In the citing paper
“Mutations affecting the TREM2 function impair microglial activation (37) and reduce their ability to accumulate LDs in the AD brain (38).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [37]
In the citing paper
“Loss-of-function (LOF) variants of TREM2, an immune receptor expressed in microglia, increase Alzheimer’s disease risk.”
From TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“Certain TREM2 LOAD variants, including R47H, show reduced affinity to lipids”
From TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“Most notably, a hypomorphic variant in the microglial receptor TREM2, R47H, increases the risk of AD several fold, as do other TREM2 variants, such as R62H, although with reduced penetrance14.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [14]
In the citing paper
“AD patients carrying the R47H variant, who have a higher risk (2-4-fold) of developing AD than do R62H carriers.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [14]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Self-citation2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Research works printed but not linked: 3
- Nissl, F. in Histologische und histopathologische Arbeiten über die Grosshirnrinde Vol. 1 (eds. Nissl, F., Alzheimer, A.) 315–494 (G. Fischer, Jena, Germany, 1904).
- Alzheimer, A. in Histologische und histopathologische Arbeiten über die Grosshirnrinde Vol. 3 (eds. Nissl, F., Alzheimer, A.) 401–562 (G. Fischer, Jena, Germany, 1910).
- Hortega, P. R. El tercer elemento de los centros nerviosos. III. Naturaleza probable de la microglía [Spanish]. Bol. Soc. Esp. Biol. 8, 108–115 (1919).
Cited by
Sorted by citations
Items 201–300 of 737
Genetically modified non-human primate models for research on neurodegenerative diseases
Pan, M.-T., 暨南大学粤港澳中枢神经再生研究院, 广., Zhang, H., Li, X., & Guo, X. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.197 · Cited by 36
Korvatska, O., Kiianitsa, K., Ratushny, A. V., Matsushita, M. M., Beeman, N. E., Chien, W., Satoh, J., Dorschner, M. O., Keene, C. D., Bammler, T. K., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.559342 · Cited by 31
Microglia and Cholesterol Handling: Implications for Alzheimer’s Disease
Herrera, O. M. M., & Zivkovic, A. M. (2022) · Biomedicines · doi:10.3390/biomedicines10123105 · Cited by 38
TREM2, microglial and ischemic stroke
Wang, H., Li, X., Wang, Q., Ma, J., Gao, X., & Wang, M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578108 · Cited by 32
TREM2 and Microglia Contribute to the Synaptic Plasticity: from Physiology to Pathology
Yu, C.-J., Wang, M., Ruiyang, L., Wei, T., Yang, H.-C., Yin, Y., Mi, Y., Qin, Q., & Tang, Y. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03100-1 · Cited by 34
You, Y., Chen, M., Tang, Y., Yu, W.-X., Pang, X., Chu, Y., Zhang, H., Shang, K., Deng, G., Zhou, L., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02772-3 · Cited by 32
Bac, B., Hicheri, C., Weiss, C., Buell, A., Vilcek, N., Späni, C. B., Geula, C., Savas, J. N., & Disterhoft, J. F. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.12.015 · Cited by 31
Beckman, D., Diniz, G. B., Ott, S. P., Hobson, B. A., Chaudhari, A. J., Muller, S., Chu, Y., Takano, A., Schwarz, A. J., Yeh, C., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13868 · Cited by 32
Induced pluripotent stem cell-derived macrophages as a platform for modelling human disease
Tiwari, S. K., Wong, W. J., Moreira, M., Pasqualini, C., & Ginhoux, F. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01081-x · Cited by 36
Bellelli, F., Angioni, D., Arosio, B., Vellas, B. J., & Barreto, P. D. S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102699 · Cited by 34
Lish, A. M., Ashour, N., Pearse, R. V., Galle, P. C., Orme, G. A., Heuer, S. E., Benoit, C. R., Alexander, K. D., Grogan, E. F. L., Terzioğlu, G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115777 · Cited by 35
Fleck, D., Phu, L., Verschueren, E., Hinkle, T. B., Reichelt, M., Bhangale, T., Haley, B., Wang, Y., Graham, R., Kirkpatrick, D. S., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-19.2019 · Cited by 31
Zuroff, L. R., Torbati, T., Hart, N. J., Fuchs, D.-T. S., Sheyn, J., Rentsendorj, A., Koronyo, Y., Hayden, E. Y., Teplow, D. B., Black, K. L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01449 · Cited by 29
An Overview of Astrocyte Responses in Genetically Induced Alzheimer’s Disease Mouse Models
Spanos, F., & Liddelow, S. A. (2020) · Cells · doi:10.3390/cells9112415 · Cited by 32
Osteoporosis and Dementia: Establishing a Link
Lary, C. W., Rosen, C. J., & Kiel, D. P. (2021) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4431 · Cited by 31
Xu, M., Yang, Y., Peng, J., Zhang, Y., Wu, B., He, B., Jia, Y., & Yan, T. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115914 · Cited by 32
Jagadeesh, K. A., Dey, K. K., Montoro, D. T., Mohan, R. R., Gazal, S., Engreitz, J., Xavier, R. J., Price, A. L., & Regev, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.19.436212 · Cited by 31
Tobeh, N. S., & Bruce, K. D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1259012 · Cited by 35
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Tanaka, M., Saitô, S., Inoue, T., Satoh‐Asahara, N., & Ihara, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061992 · Cited by 31
Kong, J., Du, Z., & Li, D. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00187-z · Cited by 30
Microglia and its Genetics in Alzheimer's Disease
Liang, X., Wu, H., Colt, M., Guo, X., Pluimer, B. R., Zeng, J., Dong, S., & Zhao, Z. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211105140732 · Cited by 32
Zhang, Y., Gao, H., Zheng, W., & Xu, H. J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105824 · Cited by 31
Custodia, A., Romaus‐Sanjurjo, D., Aramburu-Núñez, M., Álvarez-Rafael, D., Vázquez‐Vázquez, L., Camino-Castiñeiras, J., Leira, Y., Peleteiro, J. M. P., Aldrey, J. M., Sobrino, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158082 · Cited by 31
Cuciuc, V., Tshori, S., Grib, L., Sella, G., Tuvali, O., Volodarsky, I., Welt, M., Fassler, M., Shimoni, S., & George, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113121 · Cited by 29
Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human
Tewari, M., Michalski, S. A., & Egan, T. M. (2024) · Cells · doi:10.3390/cells13020161 · Cited by 36
TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges
Zgórzyńska, E. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103917 · Cited by 29
Lipid droplets in the nervous system: involvement in cell metabolic homeostasis
Zhang, Y., Chen, Y., Zhuang, C., Qi, J., Zhao, R. C., & Wang, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01401 · Cited by 30
Impaired microglial phagocytosis promotes seizure development
Bosco, D. B., Křemen, V., Haruwaka, K., Zhao, S., Wang, L., Ebner, B. A., Zheng, J., Xie, M., Dheer, A., Perry, J. F., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.034 · Cited by 31
Évora, A., Garcia, G., Rubi, A., Vitis, E. D., Matos, A. T., Vaz, A. R., Gervaso, F., Gigli, G., Polini, A., & Brites, D. M. T. O. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1474012 · Cited by 31
Liu, X., Baxley, S., Hebron, M. L., Turner, R. S., & Moussa, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115044 · Cited by 29
Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis
Edén, A., Simrén, J., Price, R. W., Zetterberg, H., & Gisslén, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15459 · Cited by 29
Adipoclast: a multinucleated fat-eating macrophage
Olona, A., Mukhopadhyay, S., Hateley, C., Martínez, F. O., Gordon, S., & Behmoaras, J. V. (2021) · BMC Biology · doi:10.1186/s12915-021-01181-3 · Cited by 32
Wątroba, M., & Szukiewicz, D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.962769 · Cited by 29
Haensel, D., Daniel, B., Gaddam, S., Pan, C., Fabo, T., Bjelajac, J., Jussila, A. R., Gonzalez, F., Li, N. Y., Chen, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37993-w · Cited by 29
Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases
Tian, Y.-K., Ye, D.-W., Ge, M.-M., Chen, N., Zhou, Y.-Q., & Yang, H. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220201094547 · Cited by 31
Astrocytes regulate neuronal network activity by mediating synapse remodeling
Kim, N., & Chung, W. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.09.007 · Cited by 31
Zhuang, X., Jie, L., Song, Y., Ban, R., Zhao, X., Xia, Z., Wang, Z., & Zhang, G. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08815-z · Cited by 33
Yu, H., Zhang, L., Song, B., Ren, K., Chen, X., Dai, Y., Yang, Y., Xu, Y., & Wei, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06799-3 · Cited by 33
Lipid metabolism and neuroinflammation: What is the link?
Tiwari, V., & Simons, M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241232 · Cited by 39
Animal and Cellular Models of Alzheimer’s Disease: Progress, Promise, and Future Approaches
Trujillo‐Estrada, L., Sánchez‐Mejías, E., Sanchez-Varo, R. M., García‐León, J. A., Nuñez‐Diaz, C., Dávila, J. C., Vitórica, J., LaFerla, F. M., Moreno‐González, I., Gutiérrez, A., et al. (2021) · The Neuroscientist · doi:10.1177/10738584211001753 · Cited by 30
Molecular recognition of the interaction between ApoE and the TREM2 protein
Mai, Z., Wei, W., Yu, H., Chen, Y., Wang, Y., & Ding, Y. (2022) · Translational Neuroscience · doi:10.1515/tnsci-2022-0218 · Cited by 32
Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies
Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 33
FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game
Bleuzé, L., Triaca, V., & Borreca, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.699613 · Cited by 28
Martini, A. C., Gross, T. J., Head, E., & Mapstone, M. E. (2022) · Neuron · doi:10.1016/j.neuron.2022.04.001 · Cited by 26
Wang, Z., Ma, Y., Sun, Y., Tan, L., Wang, H.-F., Yu, J., & Initiative, A. D. N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02679-5 · Cited by 29
Wang, L., Ouyang, D., Li, L., Cao, Y., Wang, Y., Gu, N., Zhang, Z., Zhao, L., Tang, S., Tang, H. D., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03337-2 · Cited by 31
Kiianitsa, K., Kurtz, I., Beeman, N. E., Matsushita, M. M., Chien, W., Raskind, W. H., & Korvatska, O. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.2hi0720-463rr · Cited by 25
Dionisio-Santos, D. A., Karaahmet, B., Belcher, E. K., Owlett, L. D., Trojanczyk, L., Olschowka, J. A., & O’Banion, M. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.758677 · Cited by 27
Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
Qiao, W., Chen, Y., Zhong, J., Madden, B. J., Charlesworth, C. M., Martens, Y. A., Liu, C., Knight, J. A., Ikezu, T. C., Kurti, A., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00599-3 · Cited by 28
TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas
Zheng, J., Wang, L., Zhao, S., Zhang, W., Chang, Y., Bosco, D. B., Huang, T., Dheer, A., Gao, S., Xu, S., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad214 · Cited by 32
Association study of serum soluble TREM2 with vascular dementia in Chinese Han population
Wang, Q., Xu, Y., Qi, C., Liu, A., & Zhao, Y. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1702548 · Cited by 26
Alemán-Villa, K. M., Armienta-Rojas, D. A., Camberos-Barraza, J., Rábago-Monzón, Á. R., Camacho-Zamora, A., Osuna‐Ramos, J. F., Magaña‐Gómez, J. A., Guadrón‐Llanos, A. M., Calderón-Zamora, L., Norzagaray-Valenzuela, C. D., et al. (2025) · NeuroImmunoModulation · doi:10.1159/000548021 · Cited by 34
Vishnumukkala, T., Nassir, C. M. N. C. M., Hein, Z. M., Gopalakrishna, P. K., Karikalan, B., Alkatiri, A., Jagadeesan, S., Naik, V. R., Thomas, W., Moklas, M. A. M., et al. (2025) · Cells · doi:10.3390/cells14191497 · Cited by 30
Knowledge gaps in Alzheimer's disease immune biomarker research
Morgan, D., & Mielke, M. M. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12342 · Cited by 26
Fibrin-targeting immunotherapy for dementia
Kantor, A. B., Akassoglou, K., & Stavenhagen, J. B. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.105 · Cited by 24
Exploring the Disease-Associated Microglia State in Amyotrophic Lateral Sclerosis
Jauregui, C., Blanco‐Luquin, I., Macías, M., Roldán, M., Caballero, C., Pagola, I., Mendióroz, M., & Jericó, I. (2023) · Biomedicines · doi:10.3390/biomedicines11112994 · Cited by 27
Berberine modulates microglial polarization by activating TYROBP in Alzheimer's disease
Yu, Y., Wu, J., Jia, L., Feng, S., Qi, Z., Yu, H., Wu, Y., & Wang, S. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156237 · Cited by 24
TREM2+ macrophages: a key role in disease development
Wang, X., Wang, Y., Yang, L. X., Zhang, Y., & Yang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550893 · Cited by 29
Huang, Y., & Fang, W. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01152-9 · Cited by 30
Hassan, H., Rawlinson, C., Lan, Y., Jenkins, S. I., & Chen, R. (2025) · Biomolecules · doi:10.3390/biom15111629 · Cited by 30
Xu, D., Xu, Y., Gao, X., Yan, M., Zhang, C., Wu, X., Xia, Q., & Ge, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110903 · Cited by 25
Kim, Y. W., Al‐Ramahi, I., Koire, A. M., Wilson, S. J., Konecki, D. M., Mota, S., Soleimani, S., Botas, J., & Lichtarge, O. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12240 · Cited by 22
The double-edged role and therapeutic potential of TREM2 in atherosclerosis
Zhu, B., Liu, Y., & Peng, D. (2024) · Biomarker Research · doi:10.1186/s40364-024-00675-w · Cited by 28
TREM2 in Neurodegenerative Disorders: Mutation Spectrum, Pathophysiology, and Therapeutic Targeting
Yang, H.-W., Kim, D., Yang, Y., Bagyinszky, E., & An, S. S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157057 · Cited by 26
Microglia in Alzheimer’s Disease
Süß, P., & Schlachetzki, J. C. M. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200212155234 · Cited by 26
Wu, S., Romero‐Ramírez, L., & Mey, J. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30619 · Cited by 23
Gallo, C., Manzo, E., Barra, G., Fioretto, L., Ziaco, M., Nuzzo, G., d’Ippolito, G., Ferrera, F., Contini, P., Castiglia, D., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04297-z · Cited by 23
Strategies for Manipulating Microglia to Determine Their Role in the Healthy and Diseased Brain
Parajuli, B., & Koizumi, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03742-6 · Cited by 25
Scott‐Hewitt, N., Huang, Y., & Stevens, B. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15010 · Cited by 22
Lipid in microglial biology — from material to mediator
Yamamoto, S., & Masuda, T. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00289-z · Cited by 27
Blood-brain barrier biomarkers
Zapata-Acevedo, J. F., Mantilla-Galindo, A., Vargas-Sánchez, K., & González-Reyes, R. E. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.004 · Cited by 23
Mapstone, M. E., Gross, T. J., Macciardi, F. M., Cheema, A. K., Petersen, M. E., Head, E., Handen, B. L., Klunk, W. E., Christian, B. T., Silverman, W. P., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12028 · Cited by 24
Non-genetic Heterogeneity of Macrophages in Diseases—A Medical Perspective
Gessain, G., Blériot, C., & Ginhoux, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.613116 · Cited by 24
Plasticity of human microglia and brain perivascular macrophages in aging and Alzheimer’s disease
Lee, D., Vicari, J. M., Porras, C., Spencer, C., Pjanic, M., Wang, X., Kinrot, S., Weiler, P., Kosoy, R., Bendl, J. M., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02716-6 · Cited by 32
Qiu, H., Shao, Z., Wen, X., Qu, D., Liu, Z., Chen, Z., Zhang, X., Ding, X., & Zhang, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05489-w · Cited by 25
Liu, C., & Zhou, X. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01520-5 · Cited by 22
Circadian rhythm, microglia-mediated neuroinflammation, and Alzheimer’s disease
Geng, F., Zhao, N., & Ren, Q. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106044 · Cited by 22
Microglial and TREM2 dialogues in the developing brain
Morini, R., Tagliatti, E., Bizzotto, M., & Matteoli, M. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.022 · Cited by 24
CD33 rs2455069 SNP: Correlation with Alzheimer’s Disease and Hypothesis of Functional Role
Tortora, F., Rendina, A., Angiolillo, A., Costanzo, A. D., Aniello, F., Donizetti, A., Febbraio, F., & Vitale, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073629 · Cited by 24
Microglia as a Hub for Suicide Neuropathology: Future Investigation and Prevention Targets
de Andrade, E. G., Ibáñez, F. G., & Tremblay, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.839396 · Cited by 22
Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways
Filiberti, S., Russo, M., Lonardi, S., Bugatti, M., Vermi, W., Tournier, C., & Giurisato, E. (2022) · Biomedicines · doi:10.3390/biomedicines10112709 · Cited by 25
Pereira, C. P. M., Francis-Oliveira, J., Singulani, M. P., Ferreira, A. F. F., & Britto, L. R. G. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578019 · Cited by 22
Shi, J., & Huang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010016 · Cited by 22
Large-scale imputation models for multi-ancestry proteome-wide association analysisPreprint
Wu, C., Zhang, Z., Yang, X., & Zhao, B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.05.561120 · Cited by 21
Illouz, T., Nicola, R., Ben-Shushan, L., Madar, R., Biragyn, A., & Okun, E. (2021) · Communications Biology · doi:10.1038/s42003-021-01851-6 · Cited by 21
Role of IL-34 and its receptors in inflammatory diseases
Shang, J., Xu, Y., Pu, S., Sun, X., & Gao, X. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156348 · Cited by 25
TREM2-expressing macrophages in liver diseases
Wang, X., Qiu, Z., Zhong, Z., & Liang, S. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.04.009 · Cited by 24
Shinohara, M., Tashiro, Y., Shinohara, M., Hirokawa, J., Suzuki, K., Onishi‐Takeya, M., Mukouzono, M., Takeda, S., Saito, T., Fukumori, A., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901028rr · Cited by 21
Pathways linking Alzheimer’s disease risk genes expressed highly in microglia
Hodges, A. K., Piers, T. M., Collier, D., Cousins, O., & Pocock, J. M. (2021) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2020.60 · Cited by 21
Das, M., Mao, W., Shao, E., Tamhankar, S., Yu, G.-Q., Yu, X., Ho, K., Wang, X., Wang, J., & Mucke, L. (2021) · iScience · doi:10.1016/j.isci.2021.103245 · Cited by 21
Roles of Siglecs in neurodegenerative diseases
Siew, J. J., Chern, Y., Khoo, K., & Angata, T. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101141 · Cited by 20
Current understanding on TREM-2 molecular biology and physiopathological functions
Bharadwaj, S., Groza, Y., Mierzwicka, J. M., & Malý, P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112042 · Cited by 23
Plasma membrane receptors of tissue macrophages: functions and role in pathology
Gordon, S., Plüddemann, A., & Mukhopadhyay, S. (2020) · The Journal of Pathology · doi:10.1002/path.5404 · Cited by 22
Alzheimer’s Disease, Sleep Disordered Breathing, and Microglia: Puzzling out a Common Link
Ulland, T. K., Ewald, A. C., Knutson, A. O., Marino, K. M., Smith, S. M. C., & Watters, J. J. (2021) · Cells · doi:10.3390/cells10112907 · Cited by 21
Self-citationInnate and adaptive immunity in neurodegenerative disease
Huang, Y., Zhang, G., Li, S., Feng, J., & Zhang, Z. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05533-4 · Cited by 22
Strategies and Tools for Studying Microglial-Mediated Synapse Elimination and Refinement
Morini, R., Bizzotto, M., Perrucci, F., Filipello, F., & Matteoli, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640937 · Cited by 22
Shi, K., Chen, L., Chen, L., Tan, A., Xie, G., Long, Q., Ning, F., Lan, Z., & Wang, P. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114766 · Cited by 20
Huang, W. Y., Lv, Q.-K., Xiao, Y., Zhong, Z., Hu, B., Yan, S., Yan, Y., Zhang, J., Shi, T., Jiang, L., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.745815 · Cited by 21
Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders
Rao, Y., & Peng, B. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.02.025 · Cited by 18
Metadata
- Authors
- Ulland, T. K., & Colonna, M.
- Affiliations
- University of Wisconsin–Madison (US)
- Washington University in St. Louis (US)
- Corresponding author
- Colonna, Marco
- Venue
- Nature Reviews Neurology
- Published
- 2018-09-28
- Volume
- 14
- Issue
- 11
- Pages
- 667-675
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2894203109
- Semantic Scholar
- ee2227720d29d3e454a2aa0cfa8d9df4c32b869a
- Cited by
- 735
- References
- 123
- Citations by year
- 2026: 102 · 2025: 115 · 2024: 119 · 2023: 100 · 2022: 117 · 2021: 89 · 2020: 60 · 2019: 29 · 2018: 3
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, Alzheimer's disease, microglia, disease-associated microglia, amyloid plaques, neuroinflammation, late-onset Alzheimer's disease, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Humans, Membrane Glycoproteins, Mutation, Receptors, Immunologic, Amyloid beta-Protein Precursor, Microglia, Presenilins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
